ARCHIVES

Arizona Cancer Center Convinces State To Set Lower Limits For Aflatoxin

This article is from The Cancer Letter archive.

Vol. 05 No. 08 | February 23, 1979

Download PDF Visit The Full Archive

Related Articles

Tissue of Origin Test Consistent With Diagnosis In Blinded Validation Study

January 28, 2011

NCAB Votes To ‘Keep Alive’ Concept For Stage 2 Breast Cancer Fat Trial

February 14, 1986

Deals and Collaborations: Firms Get First Payment From Bristol-Myers for Taxol

March 5, 1999

ACS Issues Challenge To cut Death Rate From Cancer In Half

November 22, 1996

FDA Issues Final Rules On Patient Access To Investigational Drugs

September 11, 2009

NLST Shows 20.3 Percent Mortality Benefit For CT Vs. X-Ray In Lung Cancer Screening

November 5, 2010